Cargando…
Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy: A randomized trial
OBJECTIVE: To assess efficacy and safety of adjunctive perampanel in patients with drug-resistant, primary generalized tonic-clonic (PGTC) seizures in idiopathic generalized epilepsy (IGE). METHODS: In this multicenter, double-blind study (ClinicalTrials.gov identifier: NCT01393743; funded by Eisai...
Autores principales: | French, Jacqueline A., Krauss, Gregory L., Wechsler, Robert T., Wang, Xue-Feng, DiVentura, Bree, Brandt, Christian, Trinka, Eugen, O'Brien, Terence J., Laurenza, Antonio, Patten, Anna, Bibbiani, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567458/ https://www.ncbi.nlm.nih.gov/pubmed/26296511 http://dx.doi.org/10.1212/WNL.0000000000001930 |
Ejemplares similares
-
Long‐term open‐label perampanel: Generalized tonic–clonic seizures in idiopathic generalized epilepsy
por: French, Jacqueline A., et al.
Publicado: (2022) -
Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies
por: Rektor, Ivan, et al.
Publicado: (2020) -
Time to exceed pre‐randomization monthly seizure count for perampanel in participants with primary generalized tonic–clonic seizures: A potential clinical end point
por: Kerr, Wesley T., et al.
Publicado: (2022) -
Open‐label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic‐clonic seizures
por: Fogarasi, Andras, et al.
Publicado: (2020) -
Clinical efficacy of perampanel for partial-onset and primary generalized tonic–clonic seizures
por: Besag, Frank MC, et al.
Publicado: (2016)